Chronic Kidney Disease Clinical Trial Results

Browse clinical trials for Chronic Kidney Disease by phase, sponsor and reported results. Data from ClinicalTrials.gov.

• Study to Evaluate the Safety and Efficacy of GSK1278863 in Recombinant Human Erythropoietin (rhEPO) Hyporespon
  Phase 2 · GlaxoSmithKline · Terminated · Jun 21, 2017
• Tacrolimus/Everolimus vs. Tacrolimus/MMF in Pediatric Heart Transplant Recipients Using the MATE Score
  Phase 3 · Boston Children's Hospital · Completed · Jul 31, 2026
• Bone in CKD Alkali Response (BICARb Pilot Trial)
  Phase 2/3 · Albert Einstein College of Medicine · Terminated · Jul 28, 2026
• Pioglitazone to Reduce Sympathetic Overactivity in CKD Patients
  Phase 4 · The University of Texas at Arlington · Terminated · Jul 27, 2026
• Efficacy, Safety and Tolerability of VS-01 in Adult Patients With Acute-on-Chronic Liver Failure and Ascites (
  Phase 2 · Genfit · Terminated · Jul 23, 2026
• High-protein Oral Supplement With Liposomal Curcumin in Adults Undergoing Hemodialysis.
  Phase 3 · University of Florida · Completed · Jun 1, 2026
• Randomized, Double-blind, Placebo-controlled, Crossover Study of Atrasentan in Subjects With IgA Nephropathy
  Phase 2 · Novartis Pharmaceuticals · Completed · Jul 20, 2026
• Peer i-Coaching for Activated Self-Management Optimization in Adolescents and Young Adults With Chronic Condit
  N/A · Duke University · Completed · Jul 28, 2025
• A Study to Learn How Well the Treatment Combination of Finerenone and Empagliflozin Works and How Safe it is C
  Phase 2 · Bayer · Completed · Jul 13, 2026
• Supporting Self-Management of Healthy Behaviors in Diabetes, Kidney Disease, and Hypertension
  N/A · University of Pennsylvania · Completed · Jul 8, 2026
• Safety & Tolerability Study of Chimeric Antigen Receptor T-Reg Cell Therapy in Living Donor Renal Transplant R
  Phase 1/2 · Sangamo Therapeutics · Completed · Jul 2, 2026
• Safety and Efficacy of Hectorol in Pediatric Patients With Chronic Kidney Disease Stage 3 and 4 With Secondary
  Phase 3 · Sanofi · Terminated · Jul 2, 2026
• A Study of Belantamab Mafodotin Monotherapy in Multiple Myeloma Participants With Normal and Varying Degree of
  Phase 1 · GlaxoSmithKline · Active, not recruiting · Jul 1, 2026
• Use of Acthar in Patients With FSGS That Will be Undergoing Renal Transplantation
  Phase 3 · University of Colorado, Denver · Completed · Mar 24, 2020
• Efficacy, Safety and Tolerability of Balcinrenone/Dapagliflozin Compared to Dapagliflozin in Adults With Chron
  Phase 2 · AstraZeneca · Completed · Jun 26, 2026

Trials by condition

Lung CancerNon-Small Cell Lung CancerBreast CancerColorectal CancerGastric CancerLiver CancerPancreatic CancerProstate CancerOvarian CancerMelanomaLeukemiaLymphomaMultiple MyelomaGlioblastomaType 2 DiabetesObesityHypertensionHeart FailureAtrial FibrillationStrokeChronic Kidney DiseaseNASH / MASHAlzheimer’s DiseaseParkinson’s DiseaseMultiple SclerosisDepressionEpilepsyALSRheumatoid ArthritisPsoriasisAtopic DermatitisCrohn’s DiseaseUlcerative ColitisLupusAsthmaCOPD

All trials